跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
LupiSarT - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
LupiSarT
Approved
STANDARD
LupiSarT
Lupin Limited - Unit 2
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
3d3f8c339445b073
Company
Lupin Limited - Unit 2
Type
Standard
Approval Details
Approval Id
3d3f8c339445b073
Drug Approval Philippines Name
LupiSarT
Product Name
LupiSarT
Registration Number
DRP-4866
Brand Name
LupiSarT
Generic Name
Irbesartan
Dosage Form
Film-Coated Tablet
Dosage Strength
150mg
Manufacturer
Lupin Limited - Unit 2
Distributor
Lupin Philippines, Inc.
Issuance Date
24 October 2023
Expiry Date
02 October 2025
Pharmacologic Category
Angiotensin-2-Receptor Blocker
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
3d3f8c339445b073
Type
Standard
Back to Philippines FDA Approvals